WASHINGTON (AP) — U.S. officials on Monday approved the first long-acting drug to protect babies and toddlers against a respiratory virus that sends tens of thousands of American children to the hospital each year.
RSV is a cold-like nuisance for most healthy people, but it can be life-threatening in the very young and the elderly.
The Food and Drug Administration approved the injection for infants and children up to 2 years old who face increased risk of severe RSV.


College of the Ozarks to host “From Missouri to Mussoorie: An Ozark Artist’s Photographic Journey in India” Art Exhibit
Veterans Homecoming Week Begins Wednesday
Carroll County Authorities Searching For Man Who Fled Traffic Stop
Election Day for Some, Others Later This Month